Form 4: Surgery Partners Exec Chairman Wayne DeVeydt Acquires 4,233 Shares of Common Stock

Wayne DeVeydt, Executive Chairman of Surgery Partners, acquired 4,233 shares of common stock at $24.21 per share on March 21, 2025, bringing his total holdings to 105,203 shares.

Summary

• On March 21, 2025, Wayne DeVeydt, the Executive Chairman of the Board of Surgery Partners, Inc., acquired 4,233 shares of the company's common stock.
• The shares were acquired at a price of $24.21 per share.
• This transaction increased DeVeydt's direct ownership to 105,203 shares of Surgery Partners common stock.
• The acquisition was in the form of restricted stock awards (RSAs) granted on March 21, 2025, which vest on the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an insider stock transaction. The acquisition of shares by the Executive Chairman could be seen as a positive signal, but it's not a major event.

Positives

• The Executive Chairman's acquisition of shares may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Surgery Partners, Wayne DeVeydt, SGRY, Executive Chairman, Stock Acquisition, Form 4, Restricted Stock Awards, Beneficial Ownership